Treatment of acute hepatitis C infection with interferon-alfa 2b monotherapy prevents development of chronic HCV infection

Early treatment of acute hepatitis C infection with interferon-alfa 2b monotherapy prevents development of chronic HCV infection. Hepatology 32(4 Pt 2): 318A, October, 2000

Early treatment of acute hepatitis C infection with monotherapy interferon alfa is effective to prevent development of chronic hepatitis. Gastroenterology 120(5 Supplement 1): A 380-A 381, April, 2001

Efficacy and tolerability of combination therapy with interferon-alfa plus ribavirin in patients with chronic hepatitis C virus infection: a single-center study in relapsers and nonresponders to previous treatment with high-dose interferon-alfa monotherapy. Current Therapeutic Research, Clinical and Experimental 64(3): 140-150, 2003

Combination of low-dose ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic hepatitis C virus-infected non-responders and relapsers after interferon alfa-2a monotherapy. Hepatology 32(4 Pt 2): 353A, October, 2000

Optimal dosing frequency of pegylated interferon alfa-2b monotherapy for chronic hepatitis C virus infection. Clinical Gastroenterology and Hepatology 3(6): 610-615, 2005

Good virological response to pegylated interferon alfa monotherapy of chronic hepatitis C infection in hemodialysis patient. Nefrologia 27(1): 77-80, 2007

Pegylated interferon alfa-2b monotherapy is superior to interferon alfa-2b for the treatment of chronic hepatitis C. Journal of Hepatology 32(Supplement 2): 29, 2000

An interim analysis of a prospective study evaluating the efficacy of combination interferon-alfa plus ribavirin in the re-treatment of patients with chronic hepatitis C who previously did not respond to interferon-alfa monotherapy. Gastroenterology 116(4 PART 2): A730, April, 1999

Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications. Hepatology 34(1): 139-145, 2001

Acute inflammatory demyelinating polyneuropathy after treatment with pegylated interferon alfa-2a in a patient with chronic hepatitis C virus infection: a case report. Journal of Medical Case Reports 6(): 278-278, 2012

Dynamics of interferon-specific gene expression in peripheral blood of interferon alfa-naïve patients with genotype 1 chronic hepatitis C infection treated with albumin-interferon alfa. Hepatology Research 35(4): 256-262, 2006

Combination of "low-dose" ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic HCV-infected non-responders and relapsers after interferon alfa-2a monotherapy. World Journal of Gastroenterology 7(2): 222-227, 2002

Lacks of influence of TT Virus co-infection on Interferon-alfa therapy of chronic hepatitis C patients; susceptibility of TTV to Interferon treatment. Journal of Gastroenterology & Hepatology 16(4): A6, April, 2001

Capillaritis associated with interferon-alfa treatment of chronic hepatitis C infection. Journal of the American Academy of Dermatology 43(5 Pt 2): 937-938, 2000

Recombinant interferon-alfa treatment in advanced KS and chronic HBV hepatitis associated with HIV infection. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS [Author] IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 401, 1993